Active ingredientViloxazine HydrochlorideCat. No. P-V043-001CAS 35604-67-2Family · Pharmaceutical analytical standards
Viloxazine
A noradrenaline reuptake inhibitor, launched in Europe in 1974 as an antidepressant and withdrawn in 2002 for commercial reasons; in 2021 it returned in the United States, in an extended-release form, for the treatment of ADHD. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It was born from research on beta blockers: some, at high doses, also affected serotonin reuptake, and chemists replaced their side chain with a morpholine ring to help the molecule reach the brain.
Go to the active ingredient →Active ingredientViloxazine HydrochlorideCat. No. P-V043-001CAS 35604-67-2
Metabolite5-Hydroxyviloxazine O-GlucuronideCat. No. P-V043-002CAS 56305-64-7
MetaboliteViloxazine N-Carbomyl Glucuronide Sodium Salt (Mixture of Diastereomers)Cat. No. P-V043-003
Isotopically labelledrac-Viloxazine-d5 HydrochlorideCat. No. P-V043-004CAS 1276483-10-3
ImpurityViloxazine Impurity 1Cat. No. P-V043-005CAS 47374-79-8
Impurity5-Hydroxy Viloxazine HClCat. No. P-V043-006CAS 56305-63-6
Impurity5-Oxo ViloxazineCat. No. P-V043-007CAS 56305-61-4
ImpurityViloxazine Impurity 2Cat. No. P-V043-008CAS 744994-03-4
ImpurityN-Methyl ViloxazineCat. No. P-V043-009CAS 48173-47-3
ImpurityViloxazine Diethoxy AnalogCat. No. P-V043-010CAS 3024393-81-2
ImpurityViloxazine Diol ImpurityCat. No. P-V043-012CAS 63834-83-3
ImpurityViloxazine Impurity 3Cat. No. P-V043-013
ImpurityViloxazine Oxirane ImpurityCat. No. P-V043-015CAS 5296-35-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.